Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro

M L Gishizky1, O N Witte

  • 1Department of Microbiology and Molecular Genetics, University of California, Los Angeles 90024.

Science (New York, N.Y.)
|May 8, 1992
PubMed

Insights

The bcr-abl oncogene initiates chronic myelogenous leukemia development but doesn't solely cause growth factor independence in multipotent progenitor cells (MPPCs). Further steps are needed for leukemogenesis, suggesting a stepwise process.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Chronic myelogenous leukemia (CML) development involves the bcr-abl oncogene.
  • Multipotent progenitor cells (MPPCs) are crucial in CML pathogenesis.

Purpose of the Study:

  • To investigate the role of bcr-abl oncogene in MPPCs.
  • To understand the initial steps of CML development.

Main Methods:

  • Bone marrow MPPCs were infected with a bcr-abl carrying retrovirus.
  • Resulting colonies were analyzed for growth factor responsiveness and differentiation.
  • Cells were injected into severe combined immunodeficient mice.

Main Results:

  • Infected MPPCs formed mixed-lineage colonies responsive to growth factors and capable of differentiation.
  • These cells acquired growth factor independence.
  • However, they were not leukemogenic in immunodeficient mice.

Conclusions:

  • bcr-abl oncogene expression alone is insufficient for causing growth factor independence.
  • Leukemogenesis is a stepwise process initiated by bcr-abl.
  • This model system can aid research on other leukemia-causing oncogenes.